Welcome to LookChem.com Sign In|Join Free

CAS

  • or

136916-19-3

Post Buying Request

136916-19-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

136916-19-3 Usage

General Description

2-Fluoro-6-nitrophenylacetic acid is a chemical compound with the molecular formula C8H6FNO4. It is a derivative of phenylacetic acid with a fluorine atom at the 2-position and a nitro group at the 6-position of the phenyl ring. 2-Fluoro-6-nitrophenylacetic acid is a known organic building block used in the synthesis of pharmaceuticals and other organic compounds. It is also used as a reagent in organic chemistry reactions and as a research tool in medicinal chemistry. The chemical properties of 2-Fluoro-6-nitrophenylacetic acid make it an important molecule for drug discovery and development.

Check Digit Verification of cas no

The CAS Registry Mumber 136916-19-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,6,9,1 and 6 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 136916-19:
(8*1)+(7*3)+(6*6)+(5*9)+(4*1)+(3*6)+(2*1)+(1*9)=143
143 % 10 = 3
So 136916-19-3 is a valid CAS Registry Number.

136916-19-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name (2-Fluoro-6-nitrophenyl)acetic acid

1.2 Other means of identification

Product number -
Other names 6-Fluor-gramin

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:136916-19-3 SDS

136916-19-3Relevant articles and documents

Design and synthesis of a novel 2-oxindole scaffold as a highly potent and brain-penetrant phosphodiesterase 10A inhibitor

Yoshikawa, Masato,Kamisaki, Haruhi,Kunitomo, Jun,Oki, Hideyuki,Kokubo, Hironori,Suzuki, Akihiro,Ikemoto, Tomomi,Nakashima, Kosuke,Kamiguchi, Naomi,Harada, Akina,Kimura, Haruhide,Taniguchi, Takahiko

, p. 7138 - 7149 (2015/11/16)

Highly potent and brain-penetrant phosphodiesterase 10A (PDE10A) inhibitors based on the 2-oxindole scaffold were designed and synthesized. (2-Oxo-1,3-oxazolidin-3-yl)phenyl derivative 1 showed the high P-glycoprotein (P-gp) efflux (efflux ratio (ER) = 6.

Design, synthesis, and SAR of new pyrrole-oxindole progesterone receptor modulators leading to 5-(7-fluoro-3,3-dimethyl-2-oxo-2,3-dihydro-1H-indol-5-yl)- 1-methyl-1H-pyrrole-2-carbonitrile (WAY-255348)

Fensome, Andrew,Adams, William R.,Adams, Andrea L.,Berrodin, Tom J.,Cohen, Jeff,Huselton, Christine,Illenberger, Arthur,Kern, Jeffrey C.,Hudak, Valerie A.,Marella, Michael A.,Melenski, Edward G.,McComas, Casey C.,Mugford, Cheryl A.,Slayden, Ov D.,Yudt, Matthew,Zhang, Zhiming,Zhang, Puwen,Zhu, Yuan,Winneker, Richard C.,Wrobel, Jay E.

, p. 1861 - 1873 (2008/12/20)

We have continued to explore the 3,3-dialkyl-5-aryloxindole series of progesterone receptor (PR) modulators looking for new agents to be used in female healthcare: contraception, fibroids, endometriosis, and certain breast cancers. Previously we reported

Substituted propylamine derivatives and methods of their use

-

Page/Page column 20, (2010/11/26)

The present invention is directed to substituted propylamine derivatives of formula I: or a pharmaceutically acceptable salt thereof, compositions containing these derivatives, and methods of their use for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia, vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders, and combinations thereof, particularly those conditions selected from the group consisting of major depressive disorder, vasomotor symptoms, stress and urge urinary incontinence, fibromyalgia, pain, diabetic neuropathy, and combinations thereof.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 136916-19-3